Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| African Americans | 14 | 2014 | 272 | 2.600 |
Why?
|
| Aged | 21 | 2014 | 607 | 1.310 |
Why?
|
| Humans | 28 | 2014 | 2493 | 1.090 |
Why?
|
| Male | 21 | 2014 | 1649 | 1.020 |
Why?
|
| Aged, 80 and over | 16 | 2014 | 246 | 1.000 |
Why?
|
| Female | 20 | 2014 | 1733 | 0.910 |
Why?
|
| Adult | 14 | 2014 | 807 | 0.860 |
Why?
|
| Retrospective Studies | 12 | 2014 | 210 | 0.840 |
Why?
|
| Gastrointestinal Hemorrhage | 5 | 2003 | 8 | 0.770 |
Why?
|
| Middle Aged | 14 | 2014 | 799 | 0.760 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 5 | 2005 | 16 | 0.630 |
Why?
|
| Pancreatitis | 2 | 2007 | 4 | 0.580 |
Why?
|
| Hepatitis C | 2 | 2006 | 8 | 0.570 |
Why?
|
| Diarrhea | 2 | 2007 | 5 | 0.540 |
Why?
|
| Colonoscopy | 3 | 2011 | 9 | 0.540 |
Why?
|
| Choledocholithiasis | 1 | 2014 | 1 | 0.510 |
Why?
|
| Pain Measurement | 1 | 2014 | 39 | 0.500 |
Why?
|
| United States | 8 | 2011 | 324 | 0.480 |
Why?
|
| Gastrointestinal Diseases | 2 | 2003 | 4 | 0.460 |
Why?
|
| Hepatic Encephalopathy | 2 | 2002 | 2 | 0.440 |
Why?
|
| Treatment Outcome | 2 | 2014 | 119 | 0.440 |
Why?
|
| Mallory-Weiss Syndrome | 1 | 2011 | 1 | 0.410 |
Why?
|
| Conscious Sedation | 1 | 2011 | 2 | 0.400 |
Why?
|
| Colorectal Neoplasms | 1 | 2011 | 21 | 0.390 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2007 | 14 | 0.380 |
Why?
|
| Risk Factors | 5 | 2011 | 240 | 0.360 |
Why?
|
| Frail Elderly | 3 | 2005 | 5 | 0.360 |
Why?
|
| Prevalence | 5 | 2007 | 114 | 0.330 |
Why?
|
| Jaundice | 1 | 2007 | 3 | 0.320 |
Why?
|
| Multiple Organ Failure | 1 | 2007 | 5 | 0.320 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2007 | 2 | 0.310 |
Why?
|
| Proton Pump Inhibitors | 1 | 2007 | 2 | 0.310 |
Why?
|
| Cross Infection | 1 | 2007 | 3 | 0.310 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2006 | 2 | 0.300 |
Why?
|
| Colonic Diseases | 1 | 2006 | 3 | 0.300 |
Why?
|
| Nursing Homes | 2 | 2005 | 3 | 0.300 |
Why?
|
| Colon | 1 | 2006 | 16 | 0.290 |
Why?
|
| HIV Infections | 2 | 2007 | 91 | 0.290 |
Why?
|
| Los Angeles | 5 | 2011 | 210 | 0.290 |
Why?
|
| Metabolic Syndrome | 1 | 2006 | 23 | 0.290 |
Why?
|
| Comorbidity | 4 | 2011 | 54 | 0.280 |
Why?
|
| Age Factors | 3 | 2014 | 90 | 0.280 |
Why?
|
| Arthritis, Infectious | 1 | 2005 | 1 | 0.270 |
Why?
|
| Interferon-alpha | 1 | 2005 | 3 | 0.270 |
Why?
|
| Antiviral Agents | 1 | 2005 | 2 | 0.270 |
Why?
|
| Fecal Incontinence | 1 | 2005 | 1 | 0.270 |
Why?
|
| Dyspepsia | 1 | 2004 | 2 | 0.250 |
Why?
|
| Myocardial Infarction | 2 | 2002 | 14 | 0.250 |
Why?
|
| Liver Diseases | 2 | 2011 | 14 | 0.250 |
Why?
|
| Succimer | 1 | 2003 | 1 | 0.240 |
Why?
|
| Chelating Agents | 1 | 2003 | 2 | 0.240 |
Why?
|
| Lead Poisoning | 1 | 2003 | 3 | 0.240 |
Why?
|
| Esophageal Diseases | 1 | 2003 | 1 | 0.240 |
Why?
|
| Wounds, Gunshot | 1 | 2003 | 13 | 0.240 |
Why?
|
| Esophagus | 1 | 2003 | 8 | 0.240 |
Why?
|
| Colonic Polyps | 1 | 2003 | 1 | 0.240 |
Why?
|
| Administration, Oral | 1 | 2003 | 19 | 0.240 |
Why?
|
| Skin Diseases | 1 | 2003 | 2 | 0.240 |
Why?
|
| Syphilis | 1 | 2003 | 1 | 0.240 |
Why?
|
| Minority Groups | 1 | 2003 | 40 | 0.230 |
Why?
|
| Anti-Infective Agents | 1 | 2003 | 3 | 0.230 |
Why?
|
| Urban Population | 3 | 2014 | 57 | 0.230 |
Why?
|
| Conjunctival Diseases | 1 | 2002 | 1 | 0.220 |
Why?
|
| Edema | 1 | 2002 | 2 | 0.220 |
Why?
|
| Liver Failure | 1 | 2002 | 3 | 0.220 |
Why?
|
| Endoscopy, Gastrointestinal | 3 | 2011 | 6 | 0.220 |
Why?
|
| Young Adult | 2 | 2014 | 175 | 0.220 |
Why?
|
| Rectum | 1 | 2000 | 6 | 0.190 |
Why?
|
| Physical Examination | 1 | 2000 | 5 | 0.190 |
Why?
|
| Abdominal Pain | 2 | 2014 | 2 | 0.190 |
Why?
|
| Cohort Studies | 2 | 2014 | 56 | 0.180 |
Why?
|
| Odds Ratio | 2 | 2014 | 35 | 0.180 |
Why?
|
| Risk Assessment | 2 | 2014 | 55 | 0.180 |
Why?
|
| California | 2 | 2014 | 93 | 0.180 |
Why?
|
| Adolescent | 2 | 2011 | 305 | 0.170 |
Why?
|
| Hospitals, Urban | 2 | 2011 | 5 | 0.160 |
Why?
|
| Biomarkers | 2 | 2007 | 58 | 0.150 |
Why?
|
| Acute Disease | 2 | 2007 | 10 | 0.150 |
Why?
|
| Case-Control Studies | 2 | 2007 | 40 | 0.130 |
Why?
|
| Biliary Tract | 1 | 2014 | 1 | 0.130 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2014 | 1 | 0.130 |
Why?
|
| Cholecystectomy | 1 | 2014 | 1 | 0.130 |
Why?
|
| Gastrointestinal Agents | 1 | 2014 | 2 | 0.130 |
Why?
|
| Confidence Intervals | 1 | 2014 | 8 | 0.130 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 27 | 0.130 |
Why?
|
| Algorithms | 2 | 2005 | 33 | 0.130 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 95 | 0.120 |
Why?
|
| Sex Factors | 1 | 2014 | 75 | 0.120 |
Why?
|
| Age Distribution | 2 | 2003 | 18 | 0.120 |
Why?
|
| Prognosis | 2 | 2003 | 47 | 0.110 |
Why?
|
| Recurrence | 1 | 2011 | 9 | 0.100 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 21 | 0.100 |
Why?
|
| Cholestasis | 1 | 2011 | 7 | 0.100 |
Why?
|
| Hypnotics and Sedatives | 1 | 2011 | 3 | 0.100 |
Why?
|
| Liver Function Tests | 1 | 2007 | 4 | 0.080 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2007 | 6 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 18 | 0.080 |
Why?
|
| Hospitalization | 1 | 2007 | 40 | 0.080 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2006 | 4 | 0.070 |
Why?
|
| Body Mass Index | 1 | 2006 | 46 | 0.070 |
Why?
|
| Inflammation | 1 | 2006 | 44 | 0.070 |
Why?
|
| Arthralgia | 1 | 2005 | 1 | 0.070 |
Why?
|
| RNA, Viral | 1 | 2005 | 5 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 33 | 0.070 |
Why?
|
| Pregnancy | 1 | 2006 | 305 | 0.070 |
Why?
|
| Pancreatitis, Alcoholic | 1 | 2004 | 2 | 0.070 |
Why?
|
| Gallstones | 1 | 2004 | 2 | 0.070 |
Why?
|
| Hospitals, Teaching | 1 | 2004 | 2 | 0.060 |
Why?
|
| Radiography | 1 | 2004 | 9 | 0.060 |
Why?
|
| Embolization, Therapeutic | 1 | 2003 | 1 | 0.060 |
Why?
|
| Sigmoidoscopy | 1 | 2003 | 2 | 0.060 |
Why?
|
| Resuscitation | 1 | 2003 | 3 | 0.060 |
Why?
|
| Decision Trees | 1 | 2003 | 3 | 0.060 |
Why?
|
| Patient Selection | 1 | 2003 | 13 | 0.060 |
Why?
|
| Anemia, Hemolytic | 1 | 2003 | 1 | 0.060 |
Why?
|
| Lead | 1 | 2003 | 2 | 0.060 |
Why?
|
| Antacids | 1 | 2003 | 1 | 0.060 |
Why?
|
| Deglutition Disorders | 1 | 2003 | 1 | 0.060 |
Why?
|
| Histamine H2 Antagonists | 1 | 2003 | 1 | 0.060 |
Why?
|
| Protons | 1 | 2003 | 1 | 0.060 |
Why?
|
| Sucralfate | 1 | 2003 | 1 | 0.060 |
Why?
|
| Endoscopy | 1 | 2003 | 2 | 0.060 |
Why?
|
| Sex Distribution | 1 | 2003 | 22 | 0.060 |
Why?
|
| Coinfection | 1 | 2003 | 1 | 0.060 |
Why?
|
| Incidence | 1 | 2003 | 55 | 0.060 |
Why?
|
| Time Factors | 1 | 2003 | 120 | 0.060 |
Why?
|
| Preventive Health Services | 1 | 2003 | 10 | 0.060 |
Why?
|
| Population Surveillance | 1 | 2003 | 19 | 0.060 |
Why?
|
| Infection Control | 1 | 2003 | 3 | 0.060 |
Why?
|
| Life Style | 1 | 2003 | 29 | 0.060 |
Why?
|
| Cellulitis | 1 | 2002 | 1 | 0.060 |
Why?
|
| Meningitis | 1 | 2002 | 1 | 0.060 |
Why?
|
| Peritonitis | 1 | 2002 | 1 | 0.060 |
Why?
|
| Sepsis | 1 | 2002 | 3 | 0.060 |
Why?
|
| Pneumonia | 1 | 2002 | 3 | 0.060 |
Why?
|
| Medical Records | 1 | 2002 | 18 | 0.060 |
Why?
|
| Urinary Tract Infections | 1 | 2002 | 4 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 24 | 0.060 |
Why?
|
| Craniocerebral Trauma | 1 | 2002 | 6 | 0.060 |
Why?
|
| Stroke | 1 | 2002 | 8 | 0.060 |
Why?
|
| Medical Audit | 1 | 2002 | 11 | 0.050 |
Why?
|
| Alcohol Drinking | 1 | 2002 | 31 | 0.050 |
Why?
|
| Safety | 1 | 2000 | 9 | 0.050 |
Why?
|
| Electrocardiography | 1 | 2000 | 18 | 0.050 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2000 | 7 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2000 | 121 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2011 | 22 | 0.030 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2011 | 12 | 0.030 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2011 | 12 | 0.030 |
Why?
|
| Social Class | 1 | 2003 | 25 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2003 | 267 | 0.010 |
Why?
|